Business Context and Reporting Period
Company: GAXOS.AI INC. (Nasdaq: GXAI)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and six months ended June 30, 2026
Business Overview: GAXOS.AI is a technology company developing AI applications across consumer and enterprise markets. Key segments include Gaxos Labs (AI tools for content creation), Gaxos Health (AI-powered wellness), and RNK Health (non-clinical administrative services). The company divested its gaming assets (Gaxos Gaming) in June 2026.
Key Financial Metrics
| Metric | Three Months Ended June 30, 2026 |
Six Months Ended June 30, 2026 |
Six Months Ended June 30, 2025 |
|---|---|---|---|
| Total Revenue | $2,457,357 | $4,266,724 | $194,703 |
| Operating Expenses | $4,322,112 | $8,678,601 | $2,569,092 |
| Loss from Operations | $(1,864,755) | $(4,411,877) | $(2,374,389) |
| Net Loss | $(22,233) | $(2,496,479) | $(2,056,634) |
| Net Income (Loss) Attributable to Common Shareholders | $241,056 | $(1,931,469) | $(1,941,188) |
| Cash and Cash Equivalents | $1,089,449 | $1,089,449 | $1,718,964 |
| Short-Term Investments | $10,353,040 | $10,353,040 | $11,345,187 |
| Working Capital | $10,769,048 | $10,769,048 | N/A |
| Net Cash Used in Operating Activities | N/A | $(3,581,332) | $(2,014,345) |
Material Changes vs. Prior Period
- Revenue Surge: Revenue increased 1,337% for the six months ended June 30, 2026, compared to the prior year period. This was driven primarily by RNK Health administrative services ($2.98M) and Gaxos Labs subscriptions ($1.28M).
- Asset Divestiture: On June 18, 2026, the company sold substantially all gaming assets to Game Foundry AI for an estimated $1.76 million in stock, recording a gain of $1,749,890. This non-operating gain significantly reduced the net loss for the quarter.
- Expense Growth: Operating expenses increased 237.8% year-over-year for the six-month period, primarily due to a 810.4% increase in advertising and marketing expenses ($5.9M vs $0.65M) to support RNK Health and Gaxos Labs.
- Capital Raise: The company raised approximately $6.32 million in net proceeds from the sale of common stock under an At-The-Market (ATM) offering agreement during the six months ended June 30, 2026.
- Investment Activity: The company invested $3.115 million in a cost-method investee (America First Defense.AI LLC) and maintained a portfolio of short-term investments totaling over $10 million.
Guidance, Outlook, and Risks
- Liquidity: Management believes existing working capital ($10.77M) and cash on hand are sufficient to meet operating needs for the next 12 months. However, the company expects to continue generating operating losses due to R&D and corporate overhead.
- Strategic Shift: The divestiture of gaming assets marks a strategic pivot away from gaming toward AI applications in health, defense, and productivity.
- Subsequent Event: On July 29, 2026, the Board approved a stock repurchase program authorizing up to $1.0 million in purchases through December 31, 2026.
- Risks: Key risks include the ability to obtain additional funding, sustain profitability, attract users/advertisers, and manage rapid growth. The company is classified as an "emerging growth company" and a "smaller reporting company."
Investor Verification Checklist
- Revenue Quality: Verify the sustainability of RNK Health revenue, which accounts for ~70% of total revenue, and the reliance on third-party medical partners.
- Marketing Efficiency: Assess the return on investment for the $5.9M spent on advertising and marketing, given the continued operating losses.
- Investment Valuation: Review the valuation methodology for the $1.76M stock consideration received from Game Foundry AI and the $3.1M investment in America First Defense.AI.
- Cash Burn Rate: Monitor the net cash used in operating activities ($3.58M for six months) against the $6.32M raised via equity to determine runway.
- Stock Repurchase Impact: Evaluate the impact of the newly authorized $1.0M stock repurchase program on liquidity and share count.